2-Methylcitricacid trisodium (Methylcitricacid) is an endogenous metabolite in the 2-methylcitricacid cycle, which accumulates in methylmalonic and propionic acidemias.
(-)-Hydroxycitricacid (HCA) can inhibit fat synthesis and reduces food intake, the primary mechanism of action of HCA appears to be related to its ability to act as a competitive inhibitor of the enzyme ATP-citrate lyase, which catalyzes the conversion of citrate and coenzyme A to oxaloacetate and acetyl coenzyme A (acetyl-CoA), primary building blocks of fatty acid and cholesterol synthesis.